7 research outputs found
Data mining for AMD screening: A classification based approach
This paper investigates the use of three alternative approaches to classifying retinal images. The novelty of these approaches is that they are not founded on individual lesion segmentation for feature generation, instead use encodings focused on the entire image. Three different mechanisms for encoding retinal image data were considered: (i) time series, (ii) tabular and (iii) tree based representations. For the evaluation two publically available, retinal fundus image data sets were used. The evaluation was conducted in the context of Age-related Macular Degeneration (AMD) screening and according to statistical significance tests. Excellent results were produced: Sensitivity, specificity and accuracy rates of 99% and over were recorded, while the tree based approach has the best performance with a sensitivity of 99.5%. Further evaluation indicated that the results were statistically significant. The excellent results indicated that these classification systems are ideally suited to large scale AMD screening processes
COVID-19 Detection Using Integration of Deep Learning Classifiers and Contrast-Enhanced Canny Edge Detected X-Ray Images
COVID-19 is a deadly disease, and should be efficiently detected. COVID-19 shares similar symptoms with pneumonia, another type of lung disease, which remains a cause of morbidity and mortality. This study aims to demonstrate an ensemble deep learning approach that can differentiate COVID-19 and pneumonia based on chest x-ray images. The original x-ray images were processed to produce two sets of images with different features. The first set was images enhanced with contrast limited adaptive histogram equalization. The second set was edge images produced by Contrast-Enhanced Canny Edge Detection. Convolutional neural networks were used to extract features from the images and train classifiers which were able to classify COVID-19, pneumonia and healthy lungs cases. Results show that the classifiers were able to differentiate x-rays of different classes, where the best performing ensemble achieved an overall accuracy of 97.90%, with a sensitivity of 99.47% and specificity of 98.94% for COVID-19 detection
Recommended from our members
Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach
Background: To investigate machine learning methods, ranging from simpler interpretable techniques to complex (non-linear) “black-box” approaches, for automated diagnosis of Age-related Macular Degeneration (AMD).
Methods: Data from healthy subjects and patients diagnosed with AMD or other retinal diseases were collected during routine visits via an Electronic Health Record (EHR) system. Patients’ attributes included demographics and, for each eye, presence/absence of major AMD-related clinical signs (soft drusen, retinal pigment epitelium, defects/ pigment mottling, depigmentation area, subretinal haemorrhage, subretinal fluid, macula thickness, macular scar, subretinal fibrosis). Interpretable techniques known as white box methods including logistic regression and decision trees as well as less interpreitable techniques known as black box methods, such as support vector machines (SVM), random forests and AdaBoost, were used to develop models (trained and validated on unseen data) to diagnose AMD. The gold standard was confirmed diagnosis of AMD by physicians. Sensitivity, specificity and area under the receiver operating characteristic (AUC) were used to assess performance.
Results: Study population included 487 patients (912 eyes). In terms of AUC, random forests, logistic regression and adaboost showed a mean performance of (0.92), followed by SVM and decision trees (0.90). All machine learning models identified soft drusen and age as the most discriminating variables in clinicians’ decision pathways to diagnose AMD. C
Conclusions: Both black-box and white box methods performed well in identifying diagnoses of AMD and their decision pathways. Machine learning models developed through the proposed approach, relying on clinical signs identified by retinal specialists, could be embedded into EHR to provide physicians with real time (interpretable) support
Decision support system for age-related macular degeneration using discrete wavelet transform
Age-related macular degeneration (AMD) affects the central vision and subsequently may lead to visual loss in people over 60 years of age. There is no permanent cure for AMD, but early detection and successive treatment may improve the visual acuity. AMD is mainly classified into dry and wet type; however, dry AMD is more common in aging population. AMD is characterized by drusen, yellow pigmentation, and neovascularization. These lesions are examined through visual inspection of retinal fundus images by ophthalmologists. It is laborious, time-consuming, and resource-intensive. Hence, in this study, we have proposed an automated AMD detection system using discrete wavelet transform (DWT) and feature ranking strategies. The first four-order statistical moments (mean, variance, skewness, and kurtosis), energy, entropy, and Gini index-based features are extracted from DWT coefficients. We have used five (t test, Kullback–Lieber Divergence (KLD), Chernoff Bound and Bhattacharyya Distance, receiver operating characteristics curve-based, and Wilcoxon) feature ranking strategies to identify optimal feature set. A set of supervised classifiers namely support vector machine (SVM), decision tree, k -nearest neighbor ( k -NN), Naive Bayes, and probabilistic neural network were used to evaluate the highest performance measure using minimum number of features in classifying normal and dry AMD classes. The proposed framework obtained an average accuracy of 93.70 %, sensitivity of 91.11 %, and specificity of 96.30 % using KLD ranking and SVM classifier. We have also formulated an AMD Risk Index using selected features to classify the normal and dry AMD classes using one number. The proposed system can be used to assist the clinicians and also for mass AMD screening programs